• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Aptus EndoSystems Inc.

Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017

December 15, 2017 By Fink Densford

Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up […]

Filed Under: Business/Financial News Tagged With: Aptus EndoSystems Inc., Asante Solutions, Avanos Medical (formerly Halyard Health), Boston Scientific, Cutera Inc., Ellipse Technologies Inc., Encision Inc., Genoptix Inc., Hologic, Johnson and Johnson, Novartis, Nuvasive, Presbia, regentys, tandemdiabetes, Tria Beauty Inc., vasculardynamics, Ventus Medical Inc., Vermillion Inc., wishbonemedical

Lumicell taps ex-Accuray COO Londy as CEO | Personnel Moves July 18, 2017

July 19, 2017 By Fink Densford

Lumicell said last week it tapped former Accuray (NSDQ:ARAY) chief operating officer Kelly Londy as its new chief exec, with founder W. Lee moving to take the role of prez & chief scientific officer. Prior to holding the COO position at Accuray, Londy has held leadership positions at GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), Lumicell said. “We are […]

Filed Under: Business/Financial News Tagged With: Accuray Inc., Aptus EndoSystems Inc., Asante Solutions, AtriCure Inc., AxoGen, C.R. Bard, Cerner Corp., Cutera Inc., Eos Imaging, GE Healthcare, Lumicell, Mannkind Corp., Personnel Moves, Philips, Ventus Medical Inc., VertiFlex Inc., Zecotec

Medtronic’s billion-dollar buying spree

September 1, 2015 By Fink Densford

Medtronic (NYSE:MDT) CEO Omar Ishrak has literally put his money where his mouth is since saying in early June that the world’s largest pure-play medtech maker would look for small-scale investments – $1.05 billion of that money, in fact. That’s Fridley, Minn.-based Medtronic’s announced spend on M&A since June 5, when Ishrak said the company would […]

Filed Under: Mergers & Acquisitions Tagged With: Aptus EndoSystems Inc., CardioInsight Technologies Inc., Medina Medical, Medtronic, RF Surgical Systems, Twelve Inc.

Two a day: Medtronic acquires Aptus Endo for $110m

June 19, 2015 By Brad Perriello

Medtronic (NYSE:MDT) announced its 2nd acquisition of the day this afternoon, saying it paid $110 million to acquire Aptus Endosystems and its Heli-FX device aortic securement device. Earlier today the Fridley, Minn.-based medical device giant said it picked up CardioInsight for $93 million. “We are excited to add this unique complementary, anchor technology to our aortic portfolio,” aortic […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Vascular Tagged With: Aptus EndoSystems Inc., Medtronic

Aptus Endosystems CE Mark for next-generation for Heli-FX

April 15, 2013 By Sony Salzman Leave a Comment

YYmeta

Aptus Endosystems won CE Mark approval in the European Union for its next-generation thoracic-length delivery system for the Heli-FX device aortic securement device.

The newly green-lighted system includes a longer delivery device and additional features to treat thoracic aortic aneurysms. According to company estimates, this patient population in Europe includes 5,000 newly diagnosed patients and 12,000 patient treated overall each year.

Filed Under: News Well, Regulatory/Compliance Tagged With: Aptus EndoSystems Inc.

Aptus Endosystems lands FDA nod for abdominal aneurysm device

September 20, 2012 By MassDevice staff Leave a Comment

Aptus Endosystems lands FDA nod for abdominal aneurysm device

Filed Under: 510(k), News Well Tagged With: Aptus EndoSystems Inc., Intelomed, K2M, NLT Spine, Opto Circuits Ltd., SuperSonic Imagine S.A.

Consumer groups urge FDA to rescind 510(k) clearance for Aptus endostapler

February 29, 2012 By MassDevice staff Leave a Comment

Aptus Endosystems HeliFX

A group of consumer advocates demanded that the FDA heighten testing requirements for certain medical devices, taking exception to the agency’s 510(k) clearance of Aptus Endosystems Inc.’s HeliFX endostapling system.

Filed Under: 510(k), Food & Drug Administration (FDA), News Well Tagged With: Aptus EndoSystems Inc., Consumers Union, Endovascular

FDA clears first stapling system to repair failed aortic grafts

November 22, 2011 By MassDevice staff Leave a Comment

Aptus Endosystems logo

Aptus Endosystems Inc. landed FDA 510(k) clearance for the first repair system designed to fix leaks and migration in implanted endografts.

An endograft is a tube used to repair a bulge in the wall of the large blood vessel that carries blood away from the heart. Aptus’ HeliFX is a minimally invasive system of staples, delivered via catheter, that allows a surgeon to reach the blood vessel and staple the top edges of the endograft to the tissue to anchor it in place.

Filed Under: Food & Drug Administration (FDA), News Well, Stent Grafts Tagged With: Aptus EndoSystems Inc., Endovascular

Former Boston Scientific CEO Tobin joins Aptus Endosystems board | Personnel Moves

October 11, 2011 By MassDevice staff Leave a Comment

James Tobin

Former Boston Scientific Corp. (NYSE:BSX) CEO James Tobin joined the board of directors at Aptus Endosystems Inc., a device company specializing in treating abdominal aortic aneurysms.

Tobin made quite a name for himself while occupying the corner office at med-tech giant Boston Scientific, where he was chief for a decade. He officially retired in July 2009 and was succeeded by Ray Elliott.

Filed Under: Cardiac Implants, News Well Tagged With: AdvaMed, Aptus EndoSystems Inc., Baxter, Boston Scientific, Capsule Tech Inc., cyberonics, Echo Therapeutics Inc., Guidant Corp., Iridex Corp., Personnel Moves

Boston Scientific’s controversial former CEO joins the board at Aptus Endosystems

October 11, 2011 By MassDevice Contributors Network Leave a Comment

SUNNYVALE, Calif.–(BUSINESS WIRE)–Aptus Endosystems, Inc., a medical device company developing advanced technology for treating abdominal aortic aneurysms (AAA), announced today the appointment of James R. Tobin to its Board of Directors. Mr. Tobin headed Boston Scientific Corporation for 10 years and was responsible for that company’s significant growth during that period.

“The Aptus team is bringing elegant new ideas to the AAA space to address clinical needs that have to date been underserved”

Filed Under: Uncategorized Tagged With: Aptus EndoSystems Inc., Boston Scientific, Personnel Moves, Press Release

Pain wars: Industry giants battle to lead the house of pain

May 23, 2011 By MassDevice staff Leave a Comment

Regulatory Roundup

Not to be outdone by Medtronic Inc. (NYSE:MDT), which touted CE Mark approval for its peripheral nerve stimulation technique, St. Jude Medical Inc. (NYSE:STJ) announced the Australian launch of its Epiducer neurostimulation therapy delivery system yesterday.

Filed Under: News Well Tagged With: Aptus EndoSystems Inc., Boston Scientific, BridgePoint Medical Inc., Cordis Corp., Elixir Medical Corp., Gen-Probe Inc., Johnson and Johnson, Maquet Cardiovascular LLC, stjudemedical

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy